L-PGDS Mediates Vagus Nerve Stimulation-Induced Neuroprotection in a Rat Model of Ischemic Stroke by Suppressing the Apoptotic Response
Autor: | Changqing Li, Lina Zhang, Xinhao Jin, Jingxi Ma, Ying Jiang, Gongwei Jia |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Male Vagus Nerve Stimulation medicine.medical_treatment Ischemia Apoptosis Pharmacology Biochemistry Neuroprotection Brain Ischemia Brain ischemia Rats Sprague-Dawley 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Cortex (anatomy) Medicine Animals Stroke biology business.industry Prostaglandin D2 synthase General Medicine medicine.disease Lipocalins Rats Intramolecular Oxidoreductases Disease Models Animal 030104 developmental biology medicine.anatomical_structure Neuroprotective Agents Anesthesia biology.protein business 030217 neurology & neurosurgery Vagus nerve stimulation |
Zdroj: | Neurochemical research. 42(2) |
ISSN: | 1573-6903 |
Popis: | The role of lipocalin prostaglandin D2 synthase (L-PGDS) in brain ischemia has not been fully clarified to date. Vagus nerve stimulation (VNS) protects against cerebral ischemia/reperfusion (I/R) injury, but the mechanisms involved need further exploration. This study investigated the role of L-PGDS in cerebral I/R and whether this process was involved in the mechanism of VNS-mediated neuroprotection. Male Sprague-Dawley rats were pretreated with a lentiviral vector (LV) through intracerebroventricular injection, followed by middle cerebral artery occlusion (MCAO) and VNS treatment. The expression of L-PGDS in the peri-infarct cortex was examined. The localization of L-PGDS was determined using double immunofluorescence staining. Neurologic scores, infarct volume and neuronal apoptosis were evaluated at 24 h after reperfusion. The expression of apoptosis-related molecules was measured by western blot analysis. The expression of L-PGDS in the peri-infarct cortex increased at 12 h, reached a peak at 24 h after reperfusion, and lasted up to 3 days. VNS treatment further enhanced the expression of L-PGDS following ischemic stroke. L-PGDS was mainly expressed in neurons in the peri-infarct cortex. I/R rats treated with VNS showed better neurological deficit scores, reduced infarct volume, and decreased neuronal apoptosis as indicated by the decreased levels of Bax and cleaved caspase-3 as well as increased levels of Bcl-2. Strikingly, the beneficial effects of VNS were weakened after L-PGDS down-regulation. In general, our results suggest that L-PGDS is a potential mediator of VNS-induced neuroprotection against I/R injury. |
Databáze: | OpenAIRE |
Externí odkaz: |